Obese type 2 diabetics and obese patients have comparable plasma phospholipid fatty acid compositions deviating from that of healthy individuals

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 5, 2004, Pages 303-308

  Rodriguez Y ^a   Giri, M ^a   Rottiers, R ^a   Christophe, A B ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; METFORMIN; PHOSPHOLIPID; PLASMALOGEN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC OBESITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LEAN BODY WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PHOSPHOLIPIDS;

EID: 4544244200     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.04.004     Document Type: Article

References (39)

1. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:2001;799-806
2. Kolaczynki J.W., Goldstein B.J. The influence of obesity on the development of non-insulin-dependent diabetes mellitus. Lockwood D.H., Heffner T.G. Obesity: Pathology and Therapy, Springer. 2000;91-119 New York
3. Zimmet P., Alberti K.G.M.M., Shaw J. Global and societal implications of the diabetes epidemic. Nature. 414:2001;782-787
4. Lands W.E.M. Long-term fat intake and biomarkers. Am. J. Clin. Nutr. 61(Suppl. 3):1995;721S-725S
5. Vessby B. Dietary fat and insulin action in humans. Br. J. Nutr. 83(Suppl. 1):2000;S91-S96
6. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann. N.Y Acad. Sci. 967:2002;183-195
7. Blaak E.E. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc. Nutr. Soc. 62:2003;753-760
8. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults. the Atherosclerotic Risk in Communities (ARIC) study Am. J. Clin. Nutr. 78:2003;91-98
9. Pelikánova T., Kohout M., Valek J., Base J., Kazdová L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism. 38:1989;188-192
10. Lovejoy J.C., Champagne C.M., Smith S.R., et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to marker of insulin resistance in men and women with a range of glucose tolerance. Metabolism. 50:2001;86-92
11. Folsom A.R., Ma J., McGovern P.G., Eckfeldt H. Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism. 45:1996;223-228
12. Agostoni C., Riva E., Bellù R., Vincenzo S.S., Grazia B.M., Giovannini M. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostagl. Leukot. Essent. Fatty Acids. 51:1994;317-321
13. Pelikánová T., Kazdová L., Chvojková S., Base J. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients. Metabolism. 50:2001;1472-1478
14. Manzato E., Roselli della Rovere G., Avogaro A., et al. The fatty acid composition of plasma phospholipids and the insulin sensitivity in elderly diabetic patients. The Pro. V.A. study. Aging Clin. Exp. Res. 14:2002;474-478
15. Das U.N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostagl. Leukot. Essent. Fatty Acids. 52:1995;387-391
16. Pelikánova T., Kohout M., Valek J., Base J., Stefka Z. Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulin-dependent) diabetic men. Metabolism. 40:1991;175-180
17. Seigneur M., Freyburger G., Gin H. Serum fatty acid profiles in type I and type II diabetes. metabolic alterations of fatty acids of the main serum lipids Diab. Res. Clin. Pract. 23:1994;169-177
18. Ratzmann K.P., Schimke E., Beitz A., Hildebrandt R., Taube C. Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications. Klin. Wochenschr. 69:1991;652-656
19. Laitinen J.H., Ahola I.E., Sarkkinen E.S., Winberg R.L., Harmaakorpi-Iivonen P.A., Uusitupa M.I. J. Am. Diet. Assoc. 93:1993;276-283
20. S. De Vriese, Seasonal variation in long-chain polyunsaturated fatty acids, in: S. De Vriese (Ed.), Essential Fatty Acids and Pregnancy, Ph. D. Thesis, Ghent, 2003, pp. 166-172.
21. Gavin J.R., Hughes H., Alberti K.G.M.M., et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diab Care. 20:1997;1183-1197
22. Tietz N.W. Clinical Guide to Laboratory Tests. 1995;268-273 WB Saunders Company, Philadelphia
23. Sapin R., Le Galudec V., Gasser F., Pinget M., Grucker D. Elecsys insulin assay. free insulin determination and the absence of cross-reactivity with Insulin-Lispro Clin. Chem. 47:2001;602-605
24. Fernández-Real J.M., Broch M., Vendrell J., Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diab. Care. 26:2003;1362-1368
25. Christophe A.B., Matthijs F. New method for the determination of the fatty acid pattern of serum lipid classes. Clin. Chim. Acta. 16:1967;39-43
26. De Vriese S.R., Christophe A.B., Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression. further evidence that lowered n-PUFAs are related to major depression Life Sci. 73:2000;3181-3187
27. Christophe A.B., Robberecht E., Franckx H., De-Baets F., Van-de-Pas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann. Nutr. Metab. 38:1994;40-47
28. Schoonjans F., Zalata A., Depuydt C.E., Comhaire F.H. Medcalc. a new computer program for medical statistics Comput. Methods Programs Biomed. 48:1995;257-262
29. D'Hondt P., Maes M., Leysen J.E., et al. Seasonal variation in platelet [3H] paroxetine binding in healthy volunteers. Relationship to climatic variables. Neuropsychopharmacology. 15:1996;187-198
30. Holman R.T., Smythe L., Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am. J. Clin. Nutr. 32:1979;2390-2399
31. Moller N., Gormsen L., Fuglsang J., Gjedsted J. Effects of ageing on insulin secretion and action. Horm. Res. 60(Suppl. 1):2003;102-104
32. Gordon E.S. Non-esterified fatty acids in blood of obese and lean subjects. Am. J. Clin. Nutr. 8:1960;740-747
33. Reaven G.M., Hollenbeck C.B., Jeng C.Y., Wu M.S., Chen Y.D. Measurement of plasma glucose, free fatty acid lactate, and insulin for 24. h in patients with NIDDM Diabetes. 37:1988;1020-1024
34. Felt V., Stajnerova M. Changes in the fatty acid composition of serum lipid fractions during acute deposition and mobilization of fat in man. Experientia. 26:1970;23
35. Phinney S.D., Davis P.G., Johnson S.B., Holman R.T. Obesity and weight loss alter serum polyunsaturated lipids in humans. Am. J. Clin. Nutr. 53:1991;831-838
36. Rössner S., Walldius G., Björvell H. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int. J. Obes. 13:1989;603-612
37. Decsi T., Molnar D., Koletzko B. Long chain polyunsaturated fatty acids in plasma lipids of obese children. Lipids. 31:1996;305-311
38. Goto I., Antoku Y., Hayakawa T. Plasma plasmalogen of the phosphoethanolamine type and angiopathy in diabetic patients. Klin. Wochenschr. 68:1990;49
39. Pan D.A., Lillioja S., Milner M.R., et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J. Clin. Invest. 96:1995;2802-2808